Halozyme to expand in San Francisco
Halozyme Therapeutics, a biotechnology company developing novel oncology and drug-delivery therapies, will be expanding its facilities by opening a satellite office on Gateway Boulevard in South San Francisco. Halozyme is based in San Diego and currently has about 200 employees.
“Given the company’s focus in oncology and growth trajectory, a satellite office in San Francisco is an important step to help us attract additional talented team members whose focus will be to expand our clinical programs and advance toward our goal of commercializing our investigational new drug, PEGPH20,” said Helen Torley, president and chief executive officer. “The Bay Area satellite location will give us the ability to augment our already strong San Diego workforce.”